USFDA grants tentative approval for generic Tadalafil Tablets

Leading pharma company Lupin Limited receives tentative FDA approval for generic Tadalafil Tablets of USP, 2.5 mg, 5 mg, 10 mg, and 20 mg.

The United States Food and Drug Administration (USFDA) gave its tentative approval to market a generic version of Eli Lilly and Company's Galls Tablets in that country.

Tadalafil Tablet is the generic version of Eli Lilly's Cialis Tablets. The medication is indicated for the treatment of erectile dysfunction and symptoms of benign prostatic hyperplasia. The annual sales for the drug is approximately US$ 1,949.2 million in the US market, according to IQVIA MAT April 2018 data.

Lupin Limited is a transnational pharma company engaged in the manufacturing of branded and generic formulations, biotech products and APIs.

On Thursday, the stock of Lupin closed at Rs. 795.25 per share, down by Rs 14.55 or 1.80 per cent on BSE. While the benchmark index BSE Sensex closed marginally down at 36,351.23, down by 22.21 points or 0.06 per cent.